SynthesisBMC cancer2014

Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review.

Xiao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.